Skip to main content
. Author manuscript; available in PMC: 2010 Apr 22.
Published in final edited form as: Neuroreport. 2009 Apr 22;20(6):606–610. doi: 10.1097/WNR.0b013e32832a0a98

Fig. 3.

Fig. 3

Effects of dopamine receptor agonists on brain-derived neurotrophic factor (BDNF) protein expression in vitro. Tissue slices were incubated with dopamine (DA), SKF383893 (SKF), or quinpirole (QUIN) at indicated concentrations for 24 h and the levels of BDNF protein assayed by enzyme-linked immunosorbent assay. The data represents the mean±SEM (n=9). Treatment of hippocampal (HIP) and striatal (STR) tissue slices with DA and SKF significantly increased BDNF protein expression. *P<0.05 compared with wells that received no treatment as determined by two-way analysis of variance followed by Tukey’s post-hoc analysis. FC, frontal cortex.